Metalert

Metalert EBITDA Margin

The EBITDA Margin of Metalert (MLRT) as of Nov 22, 2026 is -265.47 %. In the previous year, EBITDA Margin was -332.55 % — a change of -20.17% (higher).

EBITDA Margin

-265.47 %

YoY

-20.17%

Last updated:

EBITDA Margin of Metalert is 2024 -265.47 % . EBITDA Margin of Metalert was 2023 -332.55 % . It decreases by -20.17% higher compared to the previous year.

The Metalert EBITDA Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA Margin
Date
EBITDA Margin
Jan 1, 2017
-191.57 USD
Jan 1, 2018
-148.34 USD
Jan 1, 2019
12.48 USD
Jan 1, 2020
-59.21 USD
Jan 1, 2021
-150.85 USD
Jan 1, 2022
-399.60 USD
Jan 1, 2023
-332.55 USD
Jan 1, 2024
-265.47 USD
The Metalert EBITDA Margin history
YEAREBITDA MarginYoY
-265.47 %-20.17%
-332.55 %-16.78%
-399.60 %+164.90%
-150.85 %+154.76%
-59.21 %-574.40%
12.48 %-108.41%
-148.34 %-22.57%
-191.57 %+46.07%
-131.15 %-54.32%
-287.08 %-59.57%
-710.07 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Metalert Stock analysis

What does Metalert do? Metalert, Inc. generates revenue through the sale of location-sensitive remote patient health monitoring devices and wearable technology products. The company offers an end-to-end solution including hardware, software, and connectivity, utilizing GPS, Cellular, RF, NFC, and BLE technologies. Its flagship product, the GPS SmartSole, is designed for patients at risk of wandering due to conditions like Alzheimer's, dementia, autism, and traumatic brain injury. The company serves diverse segments including the United States military, foreign military, public health authorities, municipalities, first responders, and private schools. The GPS SmartSole is a key product targeting caregivers needing real-time tracking for vulnerable patients. Metalert's solutions integrate with consumer products and enterprise applications, providing comprehensive monitoring capabilities. The company's focus on healthcare and security applications drives sales to government and institutional clients rather than individual consumers. Metalert's business model centers on delivering specialized hardware and software for critical monitoring scenarios. By leveraging GPS, Cellular, RF, NFC, and BLE technologies, the company provides tailored solutions for high-risk patient populations. Its customer base spans military organizations, public health entities, and educational institutions seeking reliable tracking systems for safety and care management. Metalert is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Metalert stock

EBITDA Margin of Metalert is -265.47 % in 2024.

EBITDA Margin of Metalert changed from -332.55 % to -265.47 %, representing a -20.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA Margin Metalert since 2006 – with annual values, charts, and detailed analysis.

EBITDA Margin shows what percentage of revenue converts to EBITDA. It normalizes for depreciation and capital structure differences.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBITDA Margin's Metalert with sector peers and the industry average to assess whether it is attractive.

To evaluate EBITDA Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBITDA Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Metalert

All Key Metrics — Metalert